Lentini Renee sold IMGN
February 5, 2024 · Form 4 insider transaction
Lentini Renee sold 2,631 shares of ImmunoGen, Inc. at $29.30 per share, a transaction worth $77.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,631
Price
$29.30
Total value
$77.1K
InsiderLentini Renee
RoleOfficer
CompanyImmunoGen, Inc. (IMGN)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 5, 2024
Filing dateFebruary 6, 2024
Shares owned after14,723
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Effected pursuant to a trading plan adopted on June 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.